Literature DB >> 2512329

Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.

A von Eckardstein1, H Funke, A Henke, K Altland, A Benninghoven, G Assmann.   

Abstract

Six unrelated families with genetically determined structural variants of apo A-I were found in the course of an electrophoretic screening program for apo A-I variants in dried blood samples of newborns. The following structural variations were identified by the combined use of HPLC, time-of-flight secondary ion mass spectrometry (TOF-SIMS), and automated gas phase sequencing: Pro3----Arg (1x), Pro4----Arg (1x), and Pro165----Arg (4x). All variant carriers were heterozygous for their mutant of apo A-I. Subjects heterozygous for apo A-I(Pro165----Arg) (n = 12) were found to exhibit lower mean values for apo A-I (109 +/- 16 mg/dl) and HDL cholesterol (37 +/- 9 mg/dl) than unaffected family members (n = 9): 176 +/- 41 and 64 +/- 18 mg/dl, respectively (P less than 0.001). In 9 of 12 apo A-I(Pro165----Arg) variant carriers the concentrations of apo A-I were below the fifth percentile of sex-matched controls. By two-dimensional immunoelectrophoresis as well as by densitometry the relative concentration of the variant apo A-I in heterozygous carriers of apo A-I(Pro165----Arg) was determined to account for only 30% of the total plasma apo A-I mass instead of the expected 50%. Thus, the observed apo A-I deficiency may be largely a consequence of the decreased concentration of the variant apo A-I. In the case of the apo A-I(Pro3----Arg) mutant, densitometry of HDL apolipoproteins demonstrated a distinctly increased concentration of the variant proapo A-I relative to normal proapo A-I. This phenomenon was not observed in the apo A-I(Pro4----Arg) mutant or in other mutants. This suggests that the interspecies conserved proline residue in position 3 of mature apo A-I is functionally important for the regular enzymatic conversion of proapo A-I to mature apo A-I.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2512329      PMCID: PMC304048          DOI: 10.1172/JCI114355

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  The primary structure of apolipoprotein A-I from rabbit high-density lipoprotein.

Authors:  C Y Yang; T Yang; H J Pownall; A M Gotto
Journal:  Eur J Biochem       Date:  1986-10-15

2.  High performance liquid chromatography and time-of-flight secondary ion mass spectrometry: a new dimension in structural analysis of apolipoproteins.

Authors:  H U Jabs; G Assmann; D Greifendorf; A Benninghoven
Journal:  J Lipid Res       Date:  1986-06       Impact factor: 5.922

3.  Functional differentiation of amphiphilic helices of the apolipoproteins by hydrophobic moment analysis.

Authors:  H De Loof; M Rosseneu; R Brasseur; J M Ruysschaert
Journal:  Biochim Biophys Acta       Date:  1987-01-05

4.  A protein cofactor of lecithin:cholesterol acyltransferase.

Authors:  C J Fielding; V G Shore; P E Fielding
Journal:  Biochem Biophys Res Commun       Date:  1972-02-25       Impact factor: 3.575

5.  AIMilano apoprotein identification of the complete kindred and evidence of a dominant genetic transmission.

Authors:  V Gualandri; G Franceschini; C R Sirtori; G Gianfranceschi; G B Orsini; A Cerrone; A Menotti
Journal:  Am J Hum Genet       Date:  1985-11       Impact factor: 11.025

Review 6.  The plasma lecithins:cholesterol acyltransferase reaction.

Authors:  J A Glomset
Journal:  J Lipid Res       Date:  1968-03       Impact factor: 5.922

7.  Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine.

Authors:  G M Anantharamaiah; J L Jones; C G Brouillette; C F Schmidt; B H Chung; T A Hughes; A S Bhown; J P Segrest
Journal:  J Biol Chem       Date:  1985-08-25       Impact factor: 5.157

8.  Studies of synthetic peptide analogs of the amphipathic helix. Correlation of structure with function.

Authors:  B H Chung; G M Anatharamaiah; C G Brouillette; T Nishida; J P Segrest
Journal:  J Biol Chem       Date:  1985-08-25       Impact factor: 5.157

9.  Tangier disease: a disorder of intracellular membrane traffic.

Authors:  G Schmitz; G Assmann; H Robenek; B Brennhausen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

10.  Familial apolipoprotein A-I and C-III deficiency, variant II.

Authors:  E J Schaefer; J M Ordovas; S W Law; G Ghiselli; M L Kashyap; L S Srivastava; W H Heaton; J J Albers; W E Connor; F T Lindgren
Journal:  J Lipid Res       Date:  1985-09       Impact factor: 5.922

View more
  14 in total

1.  Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents.

Authors:  David O Osei-Hwedieh; Marcelo Amar; Dmitri Sviridov; Alan T Remaley
Journal:  Pharmacol Ther       Date:  2010-12-21       Impact factor: 12.310

2.  Evidence of linkage of familial hypoalphalipoproteinemia to a novel locus on chromosome 11q23.

Authors:  E N Kort; D G Ballinger; W Ding; S C Hunt; B R Bowen; V Abkevich; K Bulka; B Campbell; C Capener; A Gutin; K Harshman; M McDermott; T Thorne; H Wang; B Wardell; J Wong; P N Hopkins; M Skolnick; M Samuels
Journal:  Am J Hum Genet       Date:  2000-04-17       Impact factor: 11.025

3.  Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.

Authors:  A von Eckardstein; H Holz; M Sandkamp; W Weng; H Funke; G Assmann
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

Review 4.  Apolipoprotein genes and atherosclerosis.

Authors:  J L Breslow
Journal:  Clin Investig       Date:  1992-05

5.  A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells.

Authors:  Y Huang; A von Eckardstein; S Wu; N Maeda; G Assmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

6.  Deletion of the propeptide of apolipoprotein A-I impairs exit of nascent apolipoprotein A-I from the endoplasmic reticulum.

Authors:  R S McLeod; C Robbins; A Burns; Z Yao; P H Pritchard
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

7.  A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities.

Authors:  H Funke; A von Eckardstein; P H Pritchard; M Karas; J J Albers; G Assmann
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

Review 8.  Analysis of familial hypoalphalipoproteinemia syndromes.

Authors:  J Frohlich; P H Pritchard
Journal:  Mol Cell Biochem       Date:  1992-08-18       Impact factor: 3.396

9.  Screening for naturally occurring apolipoprotein A-I variants: apo A-I(delta K107) is associated with low HDL-cholesterol levels in men but not in women.

Authors:  J R Nofer; A von Eckardstein; H Wiebusch; W Weng; H Funke; H Schulte; E Köhler; G Assmann
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

10.  Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations.

Authors:  H Paul-Hayase; M Rosseneu; D Robinson; J P Van Bervliet; J P Deslypere; S E Humphries
Journal:  Hum Genet       Date:  1992-02       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.